CU20060195A7 -
CRYSTALINE DELTA-D FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
- Google Patents
CRYSTALINE DELTA-D FORM OF IVABRADINE CHLORHYDRATE, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
Info
Publication number
CU20060195A7
CU20060195A7CU20060195ACU20060195ACU20060195A7CU 20060195 A7CU20060195 A7CU 20060195A7CU 20060195 ACU20060195 ACU 20060195ACU 20060195 ACU20060195 ACU 20060195ACU 20060195 A7CU20060195 A7CU 20060195A7
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier LabfiledCriticalServier Lab
Priority to CU20060195ApriorityCriticalpatent/CU23698B7/en
Publication of CU20060195A7publicationCriticalpatent/CU20060195A7/en
Publication of CU23698B7publicationCriticalpatent/CU23698B7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Forma cristalina delta d del clorhidrato de ivabradina de fórmula (I) (ESPACIO PARA FÓRMULA) caracterizada por su diagrama de difracción X sobre polvo. Medicamentos.Crystal form delta d of ivabradine hydrochloride of formula (I) (SPACE FOR FORMULA) characterized by its diffraction X diagram on powder. Medicines.
CU20060195A2006-10-112006-10-11
PROCEDURE FOR THE PREPARATION OF THE CRISTALINA DELTA D FORM OF IVABRADINE CHLORHYDRATE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CU23698B7
(en)
Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.